MiRNA-381 Stimulate Chondrocyte Hypertrophy by Targeting HDAC4

Z. Zhang,W. Chen,G. Huang,Y. Kang,Z. Huang,Z. Yang,P. Sheng,W. Liao
DOI: https://doi.org/10.1016/j.joca.2016.01.356
IF: 7.507
2016-01-01
Osteoarthritis and Cartilage
Abstract:Purpose: MiRNA-381 is known to regulate osteoarthritic cartilage degeneration in our previous study, but its target remains unclear. The aim of this study is to identify histone deacetylase 4 (HDAC4), an inhibitor of chondrocyte hypertrophy, as a target of miRNA-381. Methods: The long bone of forearm in mouse embryo served as an in vivo model of chondrogenesis and hypertrophy. The expression of miRNA-381was determined by in situ hybridization, while HDAC4 and MMP13 levels were detected by immunohistochemistry.SW1353 chondrocyte-like cells and primary mouse chondrocytes (PMCs) was transfected with miRNA-381 mimic or miRNA-381 inhibitor in vitro. HDAC4 siRNA was used to determine its function in chondrocyte differentiation and hypertrophy. Direct interaction between miR-381 and putative site in the 3′-untranslated region (3′-UTR) of HDAC4 messenger RNA was validated by luciferase reporter assay. Results: MiRNA-381, RUNX2 and MMP13 were mainly expressed in hypertrophic chondrocytes, while HDAC4 showed a high expression in pre-hypertrophicchondrocytes and decreased apparently in hypertrophic zone. Overexpression of miRNA-381 suppressed the activity of a reporter construct containing the 3′-UTR, decreased HDAC4 expression and increased acetylated-Histone H3, RUNX2 and MMP13. Down-regulaiton of HDAC4 using siRNA significantly increased RUNX2 expression. Conclusions: MiRNA381 epigenetically regulates chondrocyte hypertrophy and degeneration by directly targeting HDAC4.
What problem does this paper attempt to address?